Honz Pharmaceutical Co., Ltd. (SHE:300086)

China · Delayed Price · Currency is CNY

6.11

-0.06 (-0.97%)

Jul 30, 2026, 3:04 PM CST

Honz Pharmaceutical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	450.28	466.12	469.53	739.57	535.75	836.57
Revenue Growth	-5.64%	-0.73%	-36.51%	38.05%	-35.96%	-9.23%
Gross Profit	245.81	244.89	244.17	441.3	266.4	418.16
Operating Income	-158.26	-161.57	-148.86	54.84	-146.65	-5.37
Net Income	-232.2	-230.14	-215.45	11.53	-187.58	10.99
Earnings Per Share	-0.51	-0.51	-0.48	0.03	-0.42	0.02
EPS Growth	-	-	-	-	-	17.31%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Production and Sales of Daily Necessities	39.74
Pharmaceutical Manufacturing and Sales Division	431.3
Inter-Segment Elimination	-4.91
Total	466.12

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	17.27	59.75	113.19	145.09	270.11	258.99
Total Debt	434.46	446.69	510.7	501.64	583.12	592.8
Net Cash (Debt)	-417.19	-386.94	-397.52	-356.55	-313.01	-333.8
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.92	-0.85	-0.88	-0.79	-0.70	-0.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	57.8	121.24	71.46	70.69	29.32	11.33
Capital Expenditures	-22.13	-92.12	-92.5	-137.56	-58.9	-219.97
Free Cash Flow	35.67	29.12	-21.04	-66.87	-29.57	-208.64
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	54.59%	52.54%	52.00%	59.67%	49.72%	49.98%
Operating Margin	-35.15%	-34.66%	-31.70%	7.41%	-27.37%	-0.64%
Pretax Margin	-56.83%	-55.67%	-47.73%	3.17%	-41.35%	2.43%
Profit Margin	-51.57%	-49.37%	-45.89%	1.56%	-35.01%	1.31%
FCF Margin	7.92%	6.25%	-4.48%	-9.04%	-5.52%	-24.94%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	229.10	-	355.50
Forward PE	-	36.32	36.32	36.32	36.32	36.32
P/FCF Ratio	77.96	188.01	-	-	-	-
PS Ratio	6.18	11.75	4.75	3.57	5.22	4.67